Biotec Pharmacon NOK1
Biotec Pharmacon NOK1
-0,74 %
4,000 NOK
-0,03
Kurs
4,000
Hög
4,000
Förändring
-0,74 %
Låg
4,000
Uppdaterad
2019-07-17
Öppen
4,000
Factsheet for Biotec Pharmacon NOK1
Company Profile
Description
Biotec Pharmacon ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune modulating beta glucans and novel recombinant enzymes. The operating segments of the company are enzyme and beta glucans. The firm generates a majority of its revenue from beta glucans.
Key Stats
Website: https://www.biotec.no
Headquarter country: Norway
Employees: 33
Market Cap (at close 16-07-2019): NOK 195M
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings
Forward Price/Earnings
Price/Free Cash Flow
Return on Assets -21,60 -33,80 -21,90 -16,30 -26,70
Return on Equity -28,80 -44,70 -26,60 -18,80 -31,40
Return on Invested Capital -29,40 -44,90 -27,40 -20,00 -33,60
Dividend


Dividend/Share:
Ex. Dividend Date:0001-01-01
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 66,77 66,69 71,90 53,28 33,03
Gross Profit 0,05 0,04 0,05 0,04 0,02
Gross Margin % 71,00% 67,12% 62,82% 69,59% 66,57%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA -12,00 -22,00 -18,00 -16,00 -22,00
Net income -14,00 -25,00 -20,00 -17,00 -22,00
Basic Earnings Per Share -0,30 -0,56 -0,46 -0,39 -0,52
Operating Income -0,01 -0,02 -0,02 -0,02 -0,02
Operating Margin % -21,22% -37,36% -28,13% -34,70% -73,97%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -18,00 -22,00 -19,00 -13,00 -21,00
Capital Expenditures -3,00 -5,00 -1,00 -2,00 -2,00
Free Cash Flow -21,00 -27,00 -21,00 -14,00 -23,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 55,87 49,97 77,16 91,84 100,43 42,54
Long Term Assets 12,15 11,72 8,67 9,24 10,70 11,25
Total Assets 68,01 61,68 85,83 101,07 111,13 53,78
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 14,12 16,87 17,75 14,32 12,26 11,26
Long Term Liabilities 0,58 0,49
Total Liabilities 18,33 14,81
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings -146,35 -133,22 -109,82
Treasury Stock
Total Stockholder Equity 53,02 44,10 67,51 86,26 98,43 41,68
Net Tangible Assets 45,47 36,98 62,04 81,19 93,24 36,06